首页> JCO precision oncology> Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> Mutations.

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> Mutations.

导出 LinkOut

翻译打印收藏纠错

第一作者： Belinda,Kingston

第一单位： Institute of Cancer Research, London, United Kingdom.

作者： Belinda,Kingston ^[1] ; Caroline,Bailleux ^[2] ; Suzette,Delaloge ^[3] ; Gaia,Schiavon ^[4] ; Veronique,Scott ^[2] ; Magali,Lacroix-Triki ^[3] ; T Hedley,Carr ^[4] ; Iwanka,Kozarewa ^[4] ; Heidrun,Gevensleben ^[5] ; Zoe,Kemp ^[6] ; Alex,Pearson ^[1] ; Nicholas,Turner ^[7] ; Fabrice,André ^[2]

作者单位： Institute of Cancer Research, London, United Kingdom. ^[1] Institut Gustave Roussy, Villejuif, France. ^[2] Institut Gustave Roussy, Villejuif, France.;Institut Gustave Roussy, Villejuif, France. ^[3] AstraZeneca, IMED Oncology, Cambridge, United Kingdom. ^[4] Bonn University Hospital, Bonn, Germany. ^[5] The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[6] Institute of Cancer Research, London, United Kingdom.;The Royal Marsden NHS Foundation Trust, London, United Kingdom. ^[7]

DOI 10.1200/PO.19.00130

PMID 32923864

发布时间 2024-08-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JCO precision oncology

2019年3卷

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

JCO precision oncology

2019年3卷

检索历史清除

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> Mutations.

JCO precision oncology

相似文献

同项目论文

JCO precision oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline <i>PTEN</i> Mutations.

JCO precision oncology

相似文献

同项目论文

JCO precision oncology

相关期刊

检索历史清除